Verrica Pharmaceuticals Inc
Research Verrica Pharmaceuticals Inc (VRCA) on Bullrun: market cap USD 84.86M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVRCA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 84.86M
- Financial periodQ2 2026
- RevenueUSD 5.86M
- Net income-USD 13.15M
- Free cash flow-USD 9.28M
- Gross margin85.0%
Valuation Snapshot
latest market cap is USD 84.86M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 35.58M | -USD 17.90M | -USD 17.63M | 90.3% | -1.68 | USD 30.15M | USD 0 | USD 24.74M |
| FY2024 | USD 7.57M | -USD 76.60M | -USD 60.95M | 65.6% | -14.78 | USD 46.33M | USD 43.92M | -USD 9.86M |
| FY2023 | USD 5.12M | -USD 67.00M | -USD 38.94M | 90.2% | -1.48 | USD 69.55M | USD 42.87M | USD 19.76M |
| FY2022 | USD 9.03M | -USD 24.49M | -USD 18.95M | n/a | -0.72 | USD 34.27M | USD 0 | USD 40.03M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 84.86M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 76.86M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 64.25M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 307.92M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 113.01M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 252.07M | n/a | n/a | n/a |
About Verrica Pharmaceuticals Inc
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Verrica Pharmaceuticals Inc's market cap?
Verrica Pharmaceuticals Inc's market capitalization is USD 84.86M.
What does Verrica Pharmaceuticals Inc do?
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts.